Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Heart Lung Circ ; 33(3): 304-309, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38326133

RESUMO

BACKGROUND: Atrial fibrillation (AF) screening was incorporated into an abdominal aortic aneurysm screening (AAA) program for New Zealand (NZ) Maori. METHODS: AF screening was performed as an adjunct to AAA screening of Maori men aged 60-74 years and women aged 65-74 years registered with primary health care practices in Auckland, NZ. Pre-existing AF was determined through coded diagnoses or medications in the participant's primary care record. Subsequent audit of the record assessed accuracy of pre-screening coding, medication use and clinical follow-up. RESULTS: Among 1,933 people successfully screened, the prevalence of AF was 144 (7.4%), of which 46 (2.4% of the cohort) were patients without AF coded in the medical record. More than half of these were revealed to be known AF but that was not coded. Thus, the true prevalence of newly detected AF was 1.1% (n=21). An additional 48 (2.5%) of the cohort had been coded as AF but were not in AF at the time of screening. Among the 19 at-risk screen-detected people with AF, 10 started appropriate anticoagulation therapy within 6 months. Of the nine patients who did not commence anticoagulation therapy, five had a subsequent adverse clinical outcome in the follow-up period, including one with ischaemic stroke; two had contraindications to anticoagulants. Among those with previously diagnosed AF, the proportion receiving anticoagulation therapy rose from 57% pre-screening to 83% at 6 months post-screening (p<0.0001); among newly diagnosed AF the proportion rose from 0% to 53% (p<0.01). CONCLUSIONS: AF screening is a feasible low-cost adjunct to AAA screening with potential to reduce ethnic inequities in stroke incidence. However, effective measures are needed to ensure that high-risk newly diagnosed AF is managed according to best practice guidelines.


Assuntos
Aneurisma da Aorta Abdominal , Fibrilação Atrial , Isquemia Encefálica , Acidente Vascular Cerebral , Feminino , Humanos , Masculino , Anticoagulantes/uso terapêutico , Aneurisma da Aorta Abdominal/diagnóstico , Aneurisma da Aorta Abdominal/epidemiologia , Aneurisma da Aorta Abdominal/induzido quimicamente , Fibrilação Atrial/diagnóstico , Fibrilação Atrial/epidemiologia , Fibrilação Atrial/tratamento farmacológico , Povo Maori , Programas de Rastreamento , Nova Zelândia/epidemiologia , Prevalência , Acidente Vascular Cerebral/etiologia , Pessoa de Meia-Idade , Idoso
2.
J Org Chem ; 81(6): 2293-301, 2016 Mar 18.
Artigo em Inglês | MEDLINE | ID: mdl-26916112

RESUMO

A stereoselective intermolecular Diels-Alder cycloaddition of an intermediate pyrazinone with both achiral and chiral acrylate-derived dienophiles provides rapid access to the bicyclo[2.2.2]diazaoctane core shared among several prenylated indole alkaloids. The product derived from cycloaddition with 2-nitroacrylate required an additional five to six synthetic operations to intercept established precursors to premalbrancheamide and brevianamide B. The chemistry detailed in this manuscript constitutes a formal total synthesis (12 steps each) of these [2.2.2]diazabicyclic natural products from proline methyl ester.


Assuntos
Alcaloides/química , Alcaloides/síntese química , Compostos Aza/química , Compostos Aza/síntese química , Produtos Biológicos/química , Produtos Biológicos/síntese química , Compostos Bicíclicos com Pontes/química , Compostos Bicíclicos com Pontes/síntese química , Piperazinas/química , Piperazinas/síntese química , Prolina/química , Compostos de Espiro/química , Compostos de Espiro/síntese química , Reação de Cicloadição , Estrutura Molecular , Prolina/análogos & derivados , Estereoisomerismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...